Hopes dashed as last HIV vaccine trial in Africa for this decade ends in failure
- December 12, 2023
- Posted by: OptimizeIAS Team
- Category: DPN Topics
No Comments
Hopes dashed as last HIV vaccine trial in Africa for this decade ends in failure
Subject : Science and Tech
Section: Health
Context:
- A trial of a human immunodeficiency virus (HIV) vaccine in Africa has been stopped after preliminary data showed it was not effective in preventing infections.
PrEPVacc:
- PrEPVacc is the study trial of Vaccine for HIV. Researchers were testing a new form of oral pre-exposure prophylaxis (PrEP), a drug that reduces the risk of getting HIV.
- It was led by African researchers with support from European scientists.
- Triel was done in Uganda, Tanzania and South Africa.
- About 39 million people worldwide are living with HIV, with more than 25 million in sub-Saharan Africa, according to the JointUnited Nations Programme on HIV/AIDS (UNAIDS) and World Health Organization (WHO).
Joint United Nations Programme on HIV?AIDS (UNAIDS):
- Established by ECOSOC resolution 1994/24 in 1994, UNAIDS officially launched in January 1996.
- The aim of UNAIDS is to help mount and support an expanded response to HIV/AIDS, one that engages the efforts of many sectors and partners from government and civil society.
- UNAIDS seeks to prevent the HIV/AIDS epidemic from becoming a severe pandemic.
- UNAIDS is headquartered in Geneva, Switzerland, where it shares some site facilities with the World Health Organization.
- It is a member of the United Nations Development Group.
Source: Down To Earth